Phosphorus containing analogues of SAHA as inhibitors of HDACs.
Phosphorus containing analogues of SAHA as inhibitors of HDACs.
复制标题
DOI:
10.1080/14756366.2022.2063281
复制
发表时间:
2022-12
影响因子:
5.6
通讯作者:
Berkman CE
中科院分区:
文献类型:
--
作者:
Pun MD;Wu HH;Olatunji FP;Kesic BN;Peters JW;Berkman CE
Histone deacetylases (HDACs) are a family of enzymes responsible for regulating DNA transcription by modulating its binding to histone proteins. HDACs are overexpressed in several types of cancers and are recognised as drug targets. Vorinostat, or suberanilohydroxamic acid (SAHA), is an histone deacetylase (HDAC) inhibitor with a hydroxamic acid as a zinc-binding group (ZBG), and it has been FDA approved for the treatment of T-cell lymphoma. In this work, phosphorus-based SAHA analogues were synthesised to assess their zinc-binding effectiveness compared to the hydroxamic acid of SAHA. Specifically, we examined phosphate, phosphoramidate and phosphorothiolate groups as isosteres of the canonical hydroxamic acid motif of conventional HDAC inhibitors. The compounds were screened for binding to HDAC enzymes from HeLa cell lysate. The most potent derivatives were then screened against HDAC3 and HDAC8 isoforms. HDAC inhibition assays demonstrated that these phosphorus-based SAHA analogs exhibited slow binding to HDACs but with greater potency than phosphonate SAHA analogs examined previously. All compounds inhibited HDACs, the most potent having an IC50 of 50 µM.
登录
查看更多内容
影响因子:
4.8
作者:
Chou, C. James;Herman, David;Gottesfeld, Joel M.
通讯作者:
Gottesfeld, Joel M.
影响因子:
14.8
作者:
Hai Y;Christianson DW
通讯作者:
Christianson DW
影响因子:
7.8
作者:
Lu H;Tonge PJ
通讯作者:
Tonge PJ
影响因子:
--
作者:
Peserico A;Simone C
通讯作者:
Simone C
影响因子:
7.3
作者:
Nardella, Flore;Halby, Ludovic;Arimondo, Paola B.
通讯作者:
Arimondo, Paola B.